title: Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer - Authors' reply.
authors.affiliation: Department of Urology, Angers University Hospital, Angers, France.
authors.forename: Abdel-Rahmène
authors.initials: AR
authors.lastname: Azzouzi
authors.affiliation: Division of Surgery and Interventional Science, University College London, London W1T 7NF, UK. Electronic address: m.emberton@ucl.ac.uk.
authors.forename: Mark
authors.initials: M
authors.lastname: Emberton
mesh_terms: D006801:Humans; D008297:Male; D010778:Photochemotherapy; D017319:Photosensitizing Agents; D011471:Prostatic Neoplasms
chemical_list: D017319:Photosensitizing Agents